tiprankstipranks

Evan Loh Insider Profile

4 Followers
Evan Loh, CEO, Director at Paratek Pharmaceuticals, holds 0.00 shares in Paratek Pharmaceuticals (Ticker: PRTK), holds 14.00K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds ― shares in Windtree Therapeutics (Ticker: WINT).
tipranks
Evan Loh

Evan Loh
Paratek Pharmaceuticals (PRTK)
CEO, Director

Ranked #82,867 out of 99,335 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

-23.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Evan Loh does not currently own shares as a corporate insider.
A breakdown of Evan Loh's holdings

Insider Roles

Windtree Therapeutics
(WINT)
Director
Roles that Evan Loh holds in companies

Most Profitable Insider Trade

Stock:
Eiger Biopharmaceuticals
(EIGRQ)
Rating:Informative Sell
Date:Mar 15, 2021 - Mar 15, 2022
Return:+46.30%
The most profitable trade made by Evan Loh

Evan Loh's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PRTK
Paratek Pharmaceuticals
Sep 21, 2023
Uninformative Sell
$0.00
EIGRQ
Eiger Biopharmaceuticals
Mar 11, 2022
Uninformative Buy
$119.00K
Windtree Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Evan Loh's performance on stock

Evan Loh insider profile FAQ

What is the percentage of profitable transactions made by Evan Loh?
The percentage of profitable transactions made by Evan Loh is 33%.
    What is the average return per transaction made by Evan Loh?
    The average return per transaction made by Evan Loh is -23.50%.
      What stocks does Evan Loh hold?
      Evan Loh holds: PRTK, EIGRQ, WINT stocks.
        What was Evan Loh’s latest transaction?
        Evan Loh latest transaction was an Uninformative Sell of ―.
          What was Evan Loh's most profitable transaction?
          Evan Loh’s most profitable transaction was an Informative Sell of EIGRQ stock on March 15, 2021. The return on the trade was 46.30%.
            What is Evan Loh's role in Paratek Pharmaceuticals?
            Evan Loh's role in Paratek Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.